Monday, August 07, 2023 9:17:59 AM
Bionano Genomics (NASDAQ: BNGO) Executes 1-for-10 Reverse Stock Split - https://lussosnews.com/bionano-genomics-nasdaq-bngo-executes-1-for-10-reverse-stock-split/
Recent BNGO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 09:11:06 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/13/2025 02:52:41 PM
- Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results • GlobeNewswire Inc. • 01/13/2025 01:00:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/08/2025 10:29:30 PM
- Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia • GlobeNewswire Inc. • 01/07/2025 01:00:00 PM
- Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 01/06/2025 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2025 12:10:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/06/2025 12:00:46 PM
- Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 01/03/2025 07:34:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2025 01:30:17 PM
- Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway • GlobeNewswire Inc. • 12/31/2024 08:26:02 PM
- Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis • GlobeNewswire Inc. • 12/23/2024 01:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/19/2024 01:06:25 PM
- Bionano Announces the Publication of Stockholder Letter Regarding Support for Proxy Proposal • GlobeNewswire Inc. • 12/19/2024 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/05/2024 10:01:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/05/2024 10:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/02/2024 09:54:52 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/25/2024 10:24:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 09:03:33 PM
- Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress • GlobeNewswire Inc. • 11/13/2024 09:01:00 PM
- Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024 • GlobeNewswire Inc. • 11/07/2024 09:01:00 PM
- Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules • GlobeNewswire Inc. • 10/31/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 12:50:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/31/2024 12:43:48 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/31/2024 12:15:16 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM